Smart Healthcare Market (2025-2034)

How Large Is the Opportunity in the Smart Healthcare Market and What Is Driving Adoption?

The Global Smart Healthcare Market was valued at USD 215.95 billion in 2025 and is projected to reach USD 634.40 billion by 2034, advancing at a CAGR of 12.72%. Smart Healthcare combines connected medical devices, interoperable health records, AI-enabled clinical software, remote monitoring, telemedicine and data-driven hospital infrastructure. Demand is moving beyond technology trials because providers now need to monitor more patients without adding equivalent physical capacity. U.S. Medicare payments for remote patient monitoring exceeded USD 500 million in 2024, while hospital RPM availability rose from 33.0% in 2018 to 46.3% in 2022.

The application base is also widening. The FDA maintains a growing list of authorized AI-enabled medical devices, with radiology representing the largest concentration of cleared use cases, reinforcing clinical imaging as an early commercial entry point for healthcare AI. At the infrastructure level, 86% of U.S. non-federal general acute care hospitals had adopted a 2015 Edition certified EHR by 2021, creating a broad digital foundation for connected data exchange.

Key Report Takeaways

• IoT remains the largest technology layer in Smart Healthcare, estimated at 38.8% of the 2025 market, or about USD 83.8 billion, while AI is the fastest-growing technology segment at an estimated 20.9% CAGR from a 22.6% share base.
• Remote patient monitoring commands an estimated 39.0% application share, equivalent to roughly USD 84.2 billion in 2025, while AI-enabled diagnostics is expanding fastest at about 19.7% CAGR with an estimated 19.0% share.
• Hospitals and clinics account for approximately 42.1% of Smart Healthcare spending, representing about USD 90.9 billion in 2025, whereas home-care settings are advancing fastest at an estimated 20.8% CAGR from an 18.4% share base.

Smart Healthcare Market Regulations and Standards Are Raising the Bar for Interoperability, AI and Remote Care

Smart Healthcare demand is increasingly shaped by rules governing medical-device software, health-data exchange, cybersecurity, patient privacy and reimbursement. In the U.S., FDA oversight applies when software performs functions that meet the medical-device definition, while its 2026 clinical decision support guidance further clarifies the boundary between non-device CDS and regulated software. FDA also issued 2025 recommendations covering predetermined change-control plans for AI-enabled device software, making lifecycle management increasingly important for adaptive algorithms.

ONC's HTI-1 rule adds algorithm-transparency and interoperability requirements to certified health IT and adopted USCDI Version 3 as the certification baseline from January 1, 2026. In Europe, the European Health Data Space entered into force on March 26, 2025, creating a staged framework for cross-border electronic health-data access and reuse. Reimbursement is becoming equally important: CMS's proposed CY 2027 physician-fee schedule would limit Medicare RPM and RTM payment to services furnished by clinical staff employed by the billing practice, creating a material constraint for outsourced monitoring models.

How Are Connected Technologies Reshaping the Smart Healthcare Market?

IoT remains the largest technology component, estimated at 38.8% of the global Smart Healthcare Market in 2025, equal to approximately USD 83.8 billion, because connected sensors, bedside monitors, wearables and device networks generate the continuous data required for remote and hospital-based care. The installed base is expanding as providers connect previously isolated equipment to clinical workflows. GE HealthCare combines patient monitoring, connectivity, enterprise imaging and analytics, while Philips links hospital monitoring with ambulatory monitoring and sleep and respiratory care through its Connected Care portfolio.

AI is the fastest-growing technology layer, with an estimated 22.6% share in 2025, or nearly USD 48.8 billion, and an estimated 20.9% CAGR as hospitals move from data collection toward automated interpretation, prioritization and prediction. The commercial shift is visible in diagnostic workflows where algorithms can be embedded directly into imaging and monitoring systems. For example, Siemens Healthineers, GE HealthCare and Philips are expanding AI across imaging and clinical workflows, while emerging providers such as Aidoc and Viz.ai are building software-first AI platforms for hospital decision support.

Where Is Smart Healthcare Demand Concentrating Across Care Applications?

Remote patient monitoring holds an estimated 39.0% application share of the Smart Healthcare Market in 2025, translating into roughly USD 84.2 billion, supported by reimbursement, chronic-disease management and the growing need to shift routine observation outside hospitals. U.S. hospital RPM availability increased by 40.3% between 2018 and 2022, reaching 1,797 hospitals, while hospitals with more than 300 beds had 3.7-fold higher odds of offering RPM than hospitals with fewer than 100 beds. Providers such as ResMed and Biofourmis are extending connected monitoring into respiratory management, chronic care, transitional care and hospital-at-home models.

AI-enabled diagnostics is the fastest-growing application, estimated at a 19.0% share in 2025, or approximately USD 41.0 billion, with an estimated 19.7% CAGR. Its momentum comes from the ability to insert decision support into imaging, pathology, cardiology and emergency workflows without requiring a complete replacement of hospital infrastructure. For example, Aidoc focuses on clinical AI across radiology, cardiology, neurovascular and vascular workflows, while Viz.ai combines imaging analysis with AI-powered care coordination.

Which End-User Settings Will Shape Smart Healthcare Expansion?

Hospitals and clinics represent the largest end-user group, estimated at 42.1% of Smart Healthcare demand in 2025, equivalent to about USD 90.9 billion, because large providers control extensive device fleets, EHR environments and centralized technology budgets. Scale also matters commercially. The AHA study found that RPM availability was substantially higher among larger hospitals, while rural and non-teaching hospitals lagged. Enterprise suppliers including Philips and GE HealthCare are therefore positioning integrated monitoring, interoperability, imaging, analytics and clinical workflow products as broader hospital platforms rather than isolated devices.

Home-care settings are the fastest-growing end-user environment, estimated at 18.4% of the 2025 market, or nearly USD 39.7 billion, with an estimated 20.8% CAGR. The growth is being driven by hospital-at-home programs, chronic-care monitoring and the need to reserve inpatient beds for higher-acuity cases. For example, Biofourmis provides hospital-at-home, transitional care and remote patient management solutions, while Empatica supplies connected wearable monitoring and digital biomarkers that extend continuous observation beyond conventional clinical settings.

How Is Demand Building Across the Global Smart Healthcare Market?

North America remains the leading regional market, estimated at 36.5% of global Smart Healthcare revenue in 2025, or approximately USD 78.8 billion, with an estimated CAGR of 11.6%. Demand is being sustained by established EHR infrastructure, high hospital technology spending and reimbursement-backed RPM adoption. U.S. Medicare RPM payments exceeded USD 500 million in 2024, while almost half of surveyed U.S. hospitals reported RPM availability by 2022. The United States is the clear country leader in the region. For example, Philips and GE HealthCare continue to deepen their connected monitoring and AI-enabled hospital portfolios, while ResMed has built connected respiratory care around devices and digital software.

Europe holds an estimated 27.0% share, corresponding to about USD 58.3 billion in 2025, and is projected to expand at around 12.0% CAGR. The region benefits from public-sector digital-health programs, interoperability initiatives and the movement of acute care into community and home settings. The United Kingdom leads the region in this niche, with 12,588 virtual ward beds in October 2025 and 10,049 occupied, demonstrating that decentralized monitoring is being incorporated into national capacity planning. For example, Philips is extending enterprise monitoring across health systems, while Siemens Healthineers continues to combine imaging, digital applications and AI-enabled clinical technologies as European providers modernize infrastructure.

Asia Pacific is estimated to represent 22.5% of the global market in 2025, worth approximately USD 48.6 billion, but is the fastest-expanding region at an estimated 15.3% CAGR. China leads the regional market through large-scale hospital modernization, domestic medical-technology development and growing AI deployment, while India, Japan, South Korea and Southeast Asian markets broaden demand for remote diagnostics and connected monitoring. For example, Qure.ai is expanding AI-enabled diagnostic workflows across multiple countries, while major vendors such as GE HealthCare and Siemens Healthineers continue to build AI and connected imaging capabilities suited to high-volume healthcare environments.

Latin America accounts for an estimated 8.0% of the market, or about USD 17.3 billion in 2025, with an estimated CAGR of 11.8%. Adoption is being supported by rising digital-health investment, greater use of telehealth and demand for lower-cost ways to extend specialist care beyond major urban hospitals. Brazil represents the leading country opportunity, particularly for cloud-connected monitoring and virtual care models that can serve dispersed patient populations.

The Middle East and Africa contribute an estimated 6.0% share, equal to about USD 13.0 billion in 2025, and are projected to grow at approximately 10.9% CAGR. Demand is increasingly tied to smart hospital programs, centralized health systems, chronic-disease management and investments in digital infrastructure. Saudi Arabia and the United Arab Emirates lead regional adoption, with spending increasingly focused on digitally integrated hospitals, AI-enabled diagnostics and remote-care capabilities.

Why Competitive Positioning in the Smart Healthcare Market Is Moving Toward Integrated Platforms

Competition is no longer limited to manufacturers of connected medical hardware. The market increasingly pits medical-technology companies against health IT providers, cloud platforms, AI specialists, remote-care companies and wearable-device developers. The strongest portfolios connect devices, data, clinical software and workflow rather than selling a single monitoring endpoint.

Philips has one of the broadest connected-care positions, spanning hospital patient monitoring, ambulatory monitoring, diagnostics, sleep and respiratory care, and enterprise informatics. GE HealthCare combines imaging, ultrasound, patient monitoring, diagnostic cardiology, enterprise software, AI and advanced visualization, giving it exposure from diagnosis through monitoring and therapy. Siemens Healthineers competes through medical imaging, diagnostics, digital health and AI-supported clinical workflows, while ResMed concentrates on connected respiratory and sleep care with cloud-based patient-management capabilities.

The software layer is becoming just as important. Oracle Health provides EHR and clinical applications with AI-supported workflow and interoperability features, while Epic remains a major electronic health record and patient-engagement platform. Abbott and Medtronic bring connected devices, monitoring and chronic-care technologies into cardiovascular and metabolic care; Dexcom specializes in continuous glucose monitoring; Masimo focuses on patient monitoring and connected pulse oximetry technologies; and Teladoc Health operates virtual-care and chronic-condition management services. AI specialists add another competitive axis: Aidoc and Viz.ai target clinical imaging and care coordination, Tempus builds AI around clinical and molecular data, Qure.ai focuses on diagnostic imaging and population-health applications, and Biofourmis and Huma address remote monitoring and technology-enabled care delivery.